Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)

NCT01075204 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01075204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
January 31, 2012
Enrollment
335 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tract infection